| Dr Arun Gupta, DO, MPH | |
|
105 Valley West Dr, West Des Moines, IA 50265-3902 | |
| (515) 223-4368 | |
| Not Available |
| Full Name | Dr Arun Gupta |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 10 Years |
| Location | 105 Valley West Dr, West Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619382835 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | 5101021358 (Michigan) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Greater Regional Medical Center | Creston, IA | Hospital |
| Mercyone Des Moines Medical Center | Des moines, IA | Hospital |
| Pella Regional Health Center | Pella, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Iowa Ent Center Pllc | 6406007608 | 15 |
News Archive
Meanwhile, Maryland officials say the problems with that state's enrollment website are unlikely to be fixed before the March 31 enrollment deadline. Elsewhere, California is hiring more call center workers, and Illinois is reaching out to young adults with ads in the satirical online newspaper, The Onion.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators have discovered important information about apolipoprotein L1 (ApoL1), which can contribute to the development of various forms of kidney disease.
A virus that typically infects insects could help with the development of gene therapy treatment for Hemophilia A, a condition in which even a bump on the knee can cause serious internal bleeding in people.
The International Rescue Committee today announced that it is testing and plans to deploy electronic medical records in the fight against Ebola.
› Verified 8 days ago
| Entity Name | Greater Regional Medical Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902805062 PECOS PAC ID: 9234041013 Enrollment ID: O20040205000926 |
News Archive
Meanwhile, Maryland officials say the problems with that state's enrollment website are unlikely to be fixed before the March 31 enrollment deadline. Elsewhere, California is hiring more call center workers, and Illinois is reaching out to young adults with ads in the satirical online newspaper, The Onion.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators have discovered important information about apolipoprotein L1 (ApoL1), which can contribute to the development of various forms of kidney disease.
A virus that typically infects insects could help with the development of gene therapy treatment for Hemophilia A, a condition in which even a bump on the knee can cause serious internal bleeding in people.
The International Rescue Committee today announced that it is testing and plans to deploy electronic medical records in the fight against Ebola.
› Verified 8 days ago
| Entity Name | Iowa Ent Center Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1528314960 PECOS PAC ID: 6406007608 Enrollment ID: O20121116000354 |
News Archive
Meanwhile, Maryland officials say the problems with that state's enrollment website are unlikely to be fixed before the March 31 enrollment deadline. Elsewhere, California is hiring more call center workers, and Illinois is reaching out to young adults with ads in the satirical online newspaper, The Onion.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators have discovered important information about apolipoprotein L1 (ApoL1), which can contribute to the development of various forms of kidney disease.
A virus that typically infects insects could help with the development of gene therapy treatment for Hemophilia A, a condition in which even a bump on the knee can cause serious internal bleeding in people.
The International Rescue Committee today announced that it is testing and plans to deploy electronic medical records in the fight against Ebola.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Arun Gupta, DO, MPH 105 Valley West Dr, West Des Moines, IA 50265-3902 Ph: (515) 223-4368 | Dr Arun Gupta, DO, MPH 105 Valley West Dr, West Des Moines, IA 50265-3902 Ph: (515) 223-4368 |
News Archive
Meanwhile, Maryland officials say the problems with that state's enrollment website are unlikely to be fixed before the March 31 enrollment deadline. Elsewhere, California is hiring more call center workers, and Illinois is reaching out to young adults with ads in the satirical online newspaper, The Onion.
Durata Therapeutics, Inc. today announced preliminary, top-line results for its DISCOVER 1 ("Dalbavancin for Infections of the Skin COmpared to Vancomycin at an Early Response") Phase 3 study of dalbavancin, which is under investigation for the treatment of acute bacterial skin and skin structure infections (ABSSSI) caused by susceptible gram-positive bacteria, including MRSA (methicillin resistant Staphylococcus aureus).
Investigators have discovered important information about apolipoprotein L1 (ApoL1), which can contribute to the development of various forms of kidney disease.
A virus that typically infects insects could help with the development of gene therapy treatment for Hemophilia A, a condition in which even a bump on the knee can cause serious internal bleeding in people.
The International Rescue Committee today announced that it is testing and plans to deploy electronic medical records in the fight against Ebola.
› Verified 8 days ago
Dr. Danielle Sonia Liudahl, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave Ste 265, West Des Moines, IA 50266 Phone: 515-875-9450 Fax: 515-875-9457 | |
Douglas R Hoisington, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 2600 Westown Pkwy Ste 360, West Des Moines, IA 50266 Phone: 515-267-1800 Fax: 515-267-8857 | |
Dr. Richard Boyd Merrick, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 5950 University Ave, Ste 265, West Des Moines, IA 50266 Phone: 515-875-9450 Fax: 515-875-9457 | |
Timothy C Simplot, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 105 Valley West Dr, Ste 100, West Des Moines, IA 50265 Phone: 515-223-4368 Fax: 515-453-2368 | |
Dr. Brett James Baldwin, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 5950 University Ave Ste 265, West Des Moines, IA 50266 Phone: 515-875-9450 Fax: 515-875-9457 | |
Maher Younes, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1455 29th St, West Des Moines, IA 50266 Phone: 515-267-1800 Fax: 515-267-8857 | |
Thomas O Paulson, MD Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 105 Valley West Dr, Suite 100, West Des Moines, IA 50265 Phone: 515-223-4368 Fax: 515-453-2368 |